Camurus AB, a pioneering biopharmaceutical company headquartered in Sweden, focuses on developing innovative medicines for patients with severe and chronic conditions. Founded in 2016, Camurus has rapidly established itself in the pharmaceutical industry, particularly in the fields of pain management and addiction treatment. The company is renowned for its proprietary FluidCrystal® technology, which enables the formulation of long-acting injectable therapies. This unique approach enhances patient compliance and treatment outcomes. Camurus has achieved significant milestones, including the successful launch of its lead product, Buvidal®, for opioid dependence, positioning itself as a leader in the market. With a strong presence in Europe and expanding operations globally, Camurus continues to make strides in improving patient care through its advanced therapeutic solutions.
How does Camurus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Camurus's score of 41 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Camurus reported total carbon emissions of approximately 5,618,000 kg CO2e. This figure includes Scope 1 emissions of about 1,589,000 kg CO2e, primarily from mobile combustion (approximately 150,350 kg CO2e) and stationary combustion (about 8,660 kg CO2e). Scope 2 emissions totalled around 1,748,000 kg CO2e, with a market-based approach accounting for about 17,480 kg CO2e and a location-based approach contributing approximately 1,168,000 kg CO2e. Additionally, Scope 3 emissions were significant, reaching about 3,856,000 kg CO2e, with notable contributions from purchased goods and services (approximately 50,700 kg CO2e) and downstream transportation and distribution (around 287,714 kg CO2e). In comparison, the previous year, 2022, saw total emissions of about 231,600 kg CO2e, with Scope 1 emissions at approximately 162,400 kg CO2e and Scope 2 emissions at about 16,690 kg CO2e. Scope 3 emissions for 2022 were around 60,300 kg CO2e, primarily from fuel and energy-related activities. Camurus has set a long-term commitment to achieve carbon neutrality by 2040, specifically targeting reductions in Scope 1 emissions. This ambitious goal reflects the company's dedication to addressing climate change and reducing its carbon footprint. The emissions data is sourced directly from Camurus AB (publ) and is not cascaded from any parent organization.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 162,400 | 0,000,000 |
| Scope 2 | 8,990 | 00,000 |
| Scope 3 | 60,300 | 0,000,000 |
Camurus's Scope 3 emissions, which increased significantly last year and increased significantly since 2022, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 7% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Camurus has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

